Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment
New Cross-Regimen Analysis of HEALEY ALS Platform Trial Shows Significant Survival AdvantageSALT LAKE CITY, March 12, 2025 (GLOBE NEWSWIRE) -- Clene, Inc. (Nasdaq: CLNN) and its subsidiary, Clene ...
Clene announces evidence from post-hoc analysis of HEALY ALS platform trial
Clene (CLNN) and its subsidiary, Clene Nanomedicine announced new evidence from a cross-regimen, post hoc analysis of long-term survival in ...
The American Journal of Managed Care4d
Deucravacitnib Improves Quality of Life in Patients With Scalp Psoriasis
Two posters presented at the 2025 American Academy of Dermatology Annual Meeting highlighted the importance of improving ...
NETRAMARK STRENGTHENS FINANCIAL POSITION WITH ADDITIONAL $1,853,054 RAISED FROM WARRANT EXERCISE
NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a premier artificial intelligence (AI) company that is transforming clinical trials in the ...
Canadian Medical Association Journal5d
Outcomes for people experiencing homelessness with COVID-19 presenting to emergency departments in Canada, compared with housed patients
Background: Whether people experiencing homelessness (PEH) have different COVID-19 outcomes than housed patients in Canada remains unclear. We sought to ascertain whether rates of in-hospital ...